Sources | Names Used |
---|---|
CTRPv2 | crizotinib:PLX-4032 (2:1 mol/mol) |
PharmacoGx | crizotinib:PLX-4032 (2:1 mol/mol) |
Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | ORAI2 | CTRPv2 | pan-cancer | AAC | -0.15 | 0.0001 |
mRNA | GAS7 | CTRPv2 | pan-cancer | AAC | 0.16 | 0.0001 |
mRNA | SOCS3 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | NUP58 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | OR7C1 | CTRPv2 | pan-cancer | AAC | 0.13 | 0.0001 |
mRNA | KIAA1586 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | TMEM181 | CTRPv2 | pan-cancer | AAC | 0.15 | 0.0001 |
mRNA | KBTBD11 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |
mRNA | MPV17L2 | CTRPv2 | pan-cancer | AAC | -0.13 | 0.0001 |
mRNA | ZBED6 | CTRPv2 | pan-cancer | AAC | 0.14 | 0.0001 |